Decitabine Mechanism Of Action
2:21
Decitabine Mechanism Of Action
1.3K viewsApr 12, 2022
YouTubeEmad Izadi
ASCO® 2025 Summary: Dosing Decitabine & Venetoclax for Terminal Differentiation to Improve Outcomes in TP53m MDS & AML
ASCO® 2025 Summary: Dosing Decitabine & Venetoclax for Terminal Differentiation to Improve Outcomes in TP53m MDS & AML
396 views10 months ago
vumedi.com
ASCO® 2023 Insights: "Outcomes of 10-Day Decitabine With Venetoclax for AML"
ASCO® 2023 Insights: "Outcomes of 10-Day Decitabine With Venetoclax for AML"
5 months ago
vumedi.com
Ang mga epekto ng Dacogen (decitabine), pakikipag-ugnay, paggamit at imprint ng gamot - Kalusugan 2026
Ang mga epekto ng Dacogen (decitabine), pakikipag-ugnay, paggamit at imprint ng gamot - Kalusugan 2026
Aug 22, 2019
oldmedic.com
Myelodysplastic Syndrome | Dr. Tony Talebi discusses "Treatment of Myelodysplastic Syndrome?"
32:25
Myelodysplastic Syndrome | Dr. Tony Talebi discusses "Treatment of Myelodysplastic Syndrome?"
15.6K viewsJan 22, 2012
YouTubeTony
Phase I/II Study of the All-Oral Combination of Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax (SAVE) in R/R AML | OncLive
9:10
Phase I/II Study of the All-Oral Combination of Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax (SAVE) in R/R AML | OncLive
Jan 8, 2025
onclive.com
Race Oncology higher as bisantrene is combined with decitabine to enhance killing of multiple cancer cell types
Race Oncology higher as bisantrene is combined with decitabine to enhance killing of multiple cancer cell types
May 13, 2024
proactiveinvestors.com
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS
Aug 10, 2022
nejm.org
An All-Oral Regimen of Decitabine-Cedazuridine (DEC-C) Plus Venetoclax (VEN) in Patients With Newly Diagnosed AML Ineligible for Intensive Induction Chemotherapy: Results From a Phase 2 Cohort of 101 Patients | OncLive
10 months ago
onclive.com
ASCO® 2025 Insights: All-Oral Regimen of Decitabine-Cedazuridine Venetoclax in Newly Diagnosed AML Ineligible for Intensive Induction Chemo
10 months ago
vumedi.com
1:38
The search for better post-MPN AML treatment: decitabine and ruxolitinib
56 viewsOct 1, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:25
Understanding Clinical Trials in Myelodysplastic Syndromes (MDS)
661 viewsDec 16, 2024
YouTubeYou and MDS
4:35
FOCUS21-489 Video Abstract
81 viewsJan 14, 2022
VimeoJNS Publishing Group
27:22
Myelodysplastic Syndrome | Podcast
13.3K viewsMar 28, 2025
YouTubeNinja Nerd
1:02
The stages and treatments for myelodysplastic syndromes
2.7K viewsMar 6, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
6:36
MDS: Low-Risk Disease Treatment Options
3.7K viewsMar 12, 2020
YouTubeOncLive
2:33
Decitabine dosing regimens in older AML patients: 5-day vs. 10-day, is there a difference?
2.1K viewsFeb 9, 2018
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:36
Outcomes of TP53-mutant AML with venetoclax and decitabine
1.1K viewsDec 7, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
7:56
EHA22: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3+7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS
4 viewsJun 11, 2022
VimeoOncoletter
1:08
A Phase II study of low-dose subcutaneous decitabine in myelofibrosis
24 views7 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
6:24
Leucemia mieloide acuta: decitabina efficace nella 'real life'
906 viewsOct 29, 2017
YouTubePharmaStarTV
6:33
Managing and Treating MDS-related Anemia
10.8K viewsJun 26, 2019
YouTubeYou and MDS
3:18
Oral decitabine/cedazuridine for patients with myelofibrosis refractory to JAK2 inhibitors
117 viewsFeb 7, 2025
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:35
What is the Best Treatment for MDS?
19.2K viewsJan 7, 2021
YouTubeRoswell Park Comprehensive Cancer Center
2:00
Optimizing HMA treatment in HR-MDS: azacitidine versus decitabine
202 viewsFeb 6, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:54
Clinical value of decitabine monotherapy in patients with acute myeloid leukemia
148 viewsJun 15, 2023
YouTubeAJE Video Bytes
1:54
Risk-adapted therapy: three-day versus five-day oral decitabine in patients with MDS
242 viewsJun 27, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:35
Reciprocal TWIST1/OGT regulation mediates decitabine resistance in MDS/AML
45 viewsOct 3, 2023
YouTubeAJE Video Bytes
24:04
My approach to MDS management
6.7K viewsMay 5, 2017
YouTubeHMP Education
0:30
Decitabine - Dacogen use in a nutshell.
622 viewsAug 18, 2023
YouTubePharma Guru
See more